NCT06832384

Brief Summary

The objective of the current study is to describe the effectiveness of conventional and intensive physiotherapeutic intervention in improving gross motor skills (i.e. postural changes, walking and balance skills) in children affected by posterior fossa tumors

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2023

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 18, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 19, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 19, 2026

Completed
Last Updated

February 18, 2025

Status Verified

February 1, 2025

Enrollment Period

3 years

First QC Date

February 12, 2025

Last Update Submit

February 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Gross Motor Function Measure (GMFM)

    The GMFM is composed by 88 items (providing a range of score form 0 to 3 each) divided in 5 sections: A- lying and rolling; B- sitting; (C) crawling and kneeling; D - standing; E - walking, running and jumping. The total score can range between 0 (subject can't perform any gross motor activity) to a maximum of 264 (the subject completely developed his gross motor skills).

    A first assessment is provided at the enrollment and the second assessment is administered at the end of the treatment, after 4 weeks

Secondary Outcomes (5)

  • Six minutes walking test (6MWT)

    A first assessment is provided at the enrollment and the second assessment is administered at the end of the treatment, after 4 weeks

  • Scale for the Assessment and Rating of Ataxia (SARA)

    A first assessment is provided at the enrollment and the second assessment is administered at the end of the treatment, after 4 weeks

  • Pediatric Balance Scale (PBS)

    A first assessment is provided at the enrollment and the second assessment is administered at the end of the treatment, after 4 weeks

  • WeeFIM

    A first assessment is provided at the enrollment and the second assessment is administered at the end of the treatment, after 4 weeks

  • gait analysis

    A first assessment is provided at the enrollment and the second assessment is administered at the end of the treatment, after 4 weeks

Study Arms (1)

study group

Procedure: intensive physiotherapy

Interventions

the dosing of the intensive physiotherapy is of 2 sessions a day, lasting 45 minutes each, administered 5 days a week, for a period of 4 weeks. the physiotherapy is mainly addressed to the improvement of gross motor movement and balance and the training is designed according to the specific need of the subject recruited. it is not allowed the use of technological devices, excepted treadmill training.

study group

Eligibility Criteria

Age0 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children, teen agers and young adults affected by posterior fossa tumors will be collected in three different centers, nemely IRCCS Medea located in Bosisio Parini, Conegliano and Brindisi.

You may qualify if:

  • subjects who underwent to surgical resection of tumors located in posterior fossa, age between 0 and 25 years

You may not qualify if:

  • Subjects that are currently addressed to rehabilitative protocols availing of technological devices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IRCCS E. Medea

Brindisi, Brindisi, 72100, Italy

RECRUITING

IRCCS E. Medea

Bosisio Parini, Lecco, 23842, Italy

RECRUITING

IRCCS E. Medea

Conegliano, Treviso, 31015, Italy

RECRUITING

MeSH Terms

Conditions

Infratentorial Neoplasms

Condition Hierarchy (Ancestors)

Brain NeoplasmsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2025

First Posted

February 18, 2025

Study Start

January 19, 2023

Primary Completion

January 19, 2026

Study Completion

January 19, 2026

Last Updated

February 18, 2025

Record last verified: 2025-02

Locations